Healthcare AI Acquisition Corp. Faces Delisting Concerns
Ticker: HAIAF · Form: 8-K · Filed: Dec 12, 2024 · CIK: 1848861
| Field | Detail |
|---|---|
| Company | Healthcare Ai Acquisition CORP. (HAIAF) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50, $13,173.17 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
Related Tickers: HAIA
TL;DR
HAIA might get delisted - big trouble for shareholders.
AI Summary
Healthcare AI Acquisition Corp. filed an 8-K on December 12, 2024, reporting a notice of delisting or failure to satisfy continued listing rules, and other events. The company's principal executive offices are located at 418 Broadway #6434, Albany, NY 12207.
Why It Matters
This filing indicates potential issues with the company's continued listing on an exchange, which could impact its stock value and trading accessibility.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress for the company.
Key Players & Entities
- Healthcare AI Acquisition Corp. (company) — Registrant
- 0001477932-24-008044 (filing_id) — Accession Number
- December 12, 2024 (date) — Report Date
- December 10, 2024 (date) — Earliest Event Reported
- 418 Broadway #6434, Albany NY 12207 (address) — Principal Executive Offices
FAQ
What specific listing rule or standard has Healthcare AI Acquisition Corp. failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What are the implications of this notice for shareholders of Healthcare AI Acquisition Corp.?
A delisting could lead to reduced liquidity for the stock, potential price declines, and difficulty in trading the shares.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on December 10, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 418 Broadway #6434, Albany, NY 12207.
What is the Commission File Number for Healthcare AI Acquisition Corp.?
The Commission File Number for Healthcare AI Acquisition Corp. is 001-41145.
Filing Stats: 742 words · 3 min read · ~2 pages · Grade level 12.8 · Accepted 2024-12-12 16:15:23
Key Financial Figures
- $0.0001 — LLC Class A Ordinary Share, par value $0.0001 per share HAIA The Nasdaq Stock Mar
- $11.50 — able for one Class A Ordinary Share for $11.50 per share HAIAW The Nasdaq Stock Ma
- $13,173.17 — ecember 12, 2024, the Company deposited $13,173.17 into the Company's trust account in ord
Filing Documents
- haia_8k.htm (8-K) — 31KB
- 0001477932-24-008044.txt ( ) — 178KB
- haia-20241210.xsd (EX-101.SCH) — 6KB
- haia-20241210_lab.xml (EX-101.LAB) — 17KB
- haia-20241210_cal.xml (EX-101.CAL) — 1KB
- haia-20241210_pre.xml (EX-101.PRE) — 12KB
- haia-20241210_def.xml (EX-101.DEF) — 4KB
- haia_8k_htm.xml (XML) — 7KB
01. Notice of Delisting or Failure to Satisfy a Continued Listing rule or Standard; Transfer of Listing
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing rule or Standard; Transfer of Listing. On December 10, 2024 Healthcare AI Acquisition Corp. (the " Company ") received a notice (the " Notice ") from the Nasdaq Stock Market LLC (" Nasdaq "), stating that the Company did not comply with Nasdaq Interpretive Material IM-5101-2, and that its securities are now subject to delisting. The Company's registration statement, filed in connection with the Company's IPO, became effective on December 09, 2021. Pursuant to IM-5101-2, the Company, a special purpose acquisition company, must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company did not complete its initial business combination by December 09, 2024, the Company did not comply with IM-5101-2, and its securities are now subject to delisting. Unless the Company requests a timely appeal of this determination by Nasdaq, trading of the Company's securities on Nasdaq will be suspended at the opening of business on December 17, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the " SEC "), which will remove the Company's securities from listing on The Nasdaq Stock Market. The Company will not appeal Nasdaq's determination to delist the Company securities and accordingly, the Company's securities will be suspended from trading on Nasdaq at the opening of business on December 17, 2024. However, the Company expects its securities will commence trading on the over-the-counter market on December 17, 2024.
01. Other Events
Item 8.01. Other Events. On December 12, 2024, the Company deposited $13,173.17 into the Company's trust account in order to extend the amount of time it has available to complete a business combination to January 14, 2025. The Company can extend the time available to complete a business combination on a month-to-month basis, by depositing $13,173.17 for each one-month extension, until May 14, 2025. (c) Exhibits: Exhibit Description 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHCARE AI ACQUISITION CORP. Dated: December 12, 2024 By: /s/ Jiande Chen Name: Jiande Chen Title: Chief Executive Officer 3